Detalles de la búsqueda
1.
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 22(9): 1615-1620, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27264633
2.
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
Br J Haematol
; 141(2): 244-8, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18353164
3.
Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
Bone Marrow Transplant
; 41(5): 495-503, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17952130
4.
High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma.
Leuk Res
; 31(8): 1063-8, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17324463
5.
Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak.
Bone Marrow Transplant
; 39(10): 623-9, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17384657
6.
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412.
Leukemia
; 20(12): 2130-6, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17066094
7.
Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.
Leukemia
; 31(5): 1059-1068, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27795558
8.
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.
Leukemia
; 31(2): 310-317, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27624670
9.
Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.
Bone Marrow Transplant
; 52(5): 717-725, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28092349
10.
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.
Bone Marrow Transplant
; 52(8): 1120-1125, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28530668
11.
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant
; 52(3): 372-380, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27941763
12.
Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.
Leukemia
; 31(11): 2347-2354, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28322237
13.
Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT.
Bone Marrow Transplant
; 51(6): 825-32, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26901708
14.
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.
Blood Cancer J
; 6(12): e506, 2016 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27935580
15.
Interaction of aluminium and gallium with human lymphocytes: the role of transferrin.
Biochim Biophys Acta
; 1095(3): 196-200, 1991 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-1958694
16.
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit.
J Clin Oncol
; 15(2): 451-7, 1997 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-9053465
17.
Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study.
J Clin Oncol
; 15(6): 2288-95, 1997 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9196142
18.
Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT).
Bone Marrow Transplant
; 36(12): 1065-9, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16247434
19.
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation.
Bone Marrow Transplant
; 36(5): 437-41, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15980879
20.
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.
Bone Marrow Transplant
; 35(6): 609-17, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15696179